Singapore Medical Group (SMG) has reported 36.1% lower earnings of $8.7 million for the FY2020 ended December, from earnings of $13.7 million in the year before. FY2020 group revenue fell 7.7% y-o-y to $87.3 million due to lower revenue from its Diagnostic & Aesthetics Business and Health Busine...

CATALIST-listed Singapore Medical Group (SMG) on Friday posted a 36.1 per cent fall in net profit from S$13.7 million to S$8.7 million for the year ended Dec 31.

UOB Kay Hian has maintained its "buy" call on Singapore Medical Group (SMG) with a higher target price of S$0.46 compared to S$0.37 previously, following the group's Dec 20 disclosure of a possible transaction involving the company's shares.

UOB Kay Hian (UOBKH) is maintaining its “buy” call on private specialist and healthcare services provider Singapore Medical Group (SMG), but at a higher target price of 46 cents.  This is up 9 cents from its previous 37 cent call and follows the group’s Dec 18 2020, disclosure of a p...

UOB Kay Hian has maintained its "buy" call on Singapore Medical Group (SMG) with a higher target price of S$0.46 compared to S$0.37 previously, following the group's Dec 20 disclosure of a possible transaction involving the company's shares.

SINGAPORE Medical Group is in discussions with a third party regarding a possible transaction involving the company's shares, it said in a filing to the Singapore Exchange late on Friday.

Singapore Medical Group (SMG) posted 49.5% lower earnings of $3.5 million for 1H20 ended June, from the $6.8 million registered a year ago due to the “challenging market conditions”, and lower number of medical tourists, which account for some 15% to 20% of the group’s revenue. Revenue for 1H2...

SINGAPORE Medical Group (SMG) posted a 49.5 per cent drop in net profit to S$3.5 million for its first six months ended June 30, 2020, from S$6.8 million a year ago.

SINGAPORE (July 8): KGI Securities has initiated coverage on Singapore Medical Group (SMG) with an “outperform” call and target price of 34 cents, which represents a total upside of 39.0%, including a forecasted dividend yield of 1.4% for FY21F. “We assigned a fair, given the limited downside ...

KGI Securities has initiated coverage on Catalist-listed healthcare provider, Singapore Medical Group (SMG), with an "outperform" rating.